Humoral and cellular immune responses to dihydrolipoamide dehydrogenase (E3): lack of specificity for primary biliary cirrhosis

Wiley - Tập 15 Số 3 - Trang 121-125 - 1995
Hiromitsu Tanaka1, Takashi Maeda, Sachiyo Onishi, Yasunori Yamamoto
1First Department of Internal Medicine, Kochi Medical School, Japan

Tóm tắt

Abstract: Immune responses to dihydrolipoamide dehydrogenase, the E3 subunit which is a common component of 2‐oxoacid dehydrogenase complexes, have been suggested to be associated with the etiology of primary biliary cirrhosis (PBC). However, since an antibody to E3 could be detected in Caucasian patients with PBC, but was not specific for the disease, the proposal is not evident at the antibody level. We have identified the antibody also in Japanese patients with PBC by immunoblotting with sera at a 1: 100 dilution and have assessed cellular immune responses to E3 by proliferation assay of peripheral blood lymphocytes. Anti‐E3 antibody was detected more frequently in 25 of 43 PBC (58.1%) than in normal controls (p>0.01) and in chronic liver diseases (p>0.05), but the antibody was not specific for PBC as reported in Caucasian PBC. Anti‐E3 antibody‐positive sera of PBC patients or normal controls and their IgG fraction did not inhibit the enzyme activity of E3. Lymphocyte blastogenesis to E3 in PBC was significantly greater than normal controls (p>0.05), but was not significant as compared with chronic liver disease or non‐hepatic autoimmune diseases. Thus, these data do not support the hypothesis that the immune response to the E3 subunit is associated with etiology of PBC.

Từ khóa


Tài liệu tham khảo

10.1073/pnas.85.19.7317

10.1073/pnas.85.22.8654

10.1002/hep.1840090110

10.1002/hep.1840100202

10.1002/hep.1840110611

10.1042/cs0770365

Fregeau D R, 1990, Primary biliary cirrhosis: inhibition of pyruvate dehydrogenase complex activity by autoantibodies specific for E1‐, a non‐lipoic acid containing mitochondrial enzyme, J Immunol, 144, 1671, 10.4049/jimmunol.144.5.1671

10.1055/s-2008-1040507

10.1042/bst0160087

10.1002/hep.1840140608

10.7326/0003-4819-99-4-500

Kaplan M M., 1987, Primary biliary cirrhosis, Adv Intern Med, 32, 359

Ide S., 1967, Lipoamide dehydrogenase from human liver, J Biol Chem, 242, 54, 10.1016/S0021-9258(18)96317-9

10.1159/000236331

10.1042/bj2260509

10.1111/j.1749-6632.1989.tb15019.x

Water J., 1988, Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function, J Immunol, 141, 2321, 10.4049/jimmunol.141.7.2321

Kohno Y., 1986, Autoantibodies to thyroid peroxidase in patients with chronic thyroiditis: effect of antibody binding on enzyme activities, Clin Exp Immunol, 65, 534

Tan E M., 1989, Advance in immunology, 93

10.1002/hep.1840140307

Joplin R., 1992, Membrane dihydrolipoamide acetyltransferase (E2) on human biliary epithelial cells in primary biliary cirrhosis, Lancet, 339

Water J., 1991, Evidence for the targeting by 2‐oxo‐dehydrogenase enzymes in the T cell response of primary biliary cirrhosis, J Immunol, 146, 89, 10.4049/jimmunol.146.1.89

10.1002/hep.1840090311

Thông tin
Thông tin xuất bản

Wiley

Tập 15 Số 3

121-125

Thông tin tác giả